Amgen Sees FY24 Adj. EPS $19.10-$20.10 vs $17.87 Est., Total Revenues $32.8B-$33.8B vs $30.3B Est.
Portfolio Pulse from Benzinga Newsdesk
Amgen has announced its financial outlook for FY24, projecting adjusted EPS between $19.10 and $20.10, significantly higher than the estimated $17.87. The company also expects total revenues to be in the range of $32.8 billion to $33.8 billion, surpassing the estimated $30.3 billion.
August 06, 2024 | 8:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amgen's FY24 financial outlook is very positive, with adjusted EPS and total revenue projections significantly exceeding estimates. This is likely to boost investor confidence and drive the stock price up in the short term.
The significant beat on both EPS and revenue estimates indicates strong financial health and growth prospects for Amgen. This positive outlook is likely to attract investors and drive the stock price higher in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100